NewsEvents

Your Yourlocation: Home > Efficacy of salmeterol in combination with tiotropium bromide(136310-93-5) in the treatment of patients with moderate to severe chronic obstructive pulmonary disease

To evaluate the clinical efficacy of salmeterol combined with tiotropium bromide(136310-93-5) inhalation in the treatment of patients with moderate to severe COPD (chronic obstructive pulmonary disease). Studies have shown that salmeterol and tiotropium bromide(136310-93-5) inhaled tiotropium inhalation treatment of moderate and severe COPD patients with significant clinical efficacy, effectively improve the patient's symptoms of dyspnea, improve patient's lung function, it is worth applying. The article published on 2015 14th "Jilin Medical".

Forty-six patients with moderate to severe COPD were retrospectively analyzed. The clinical efficacy, blood gas analysis, dyspnea scores and pulmonary function were analyzed before and after treatment.

After treatment, the effective rate was 91.30% in the treatment group and 73.91% in the control group, the difference was statistically significant (P <0.05). After one course of treatment, all patients had dyspnea symptoms (P <0.001), but the difference between the two groups was statistically significant (P <0.001); treatment (P <0.001), the treatment group before and after treatment of dyspnea score decreased (0.73 ± 0.55), control group decreased (0.33 ± 0.65) (P> 0.05). After treatment, the lung function and blood gas index of the patients in the treatment group were better than those in the control group, the difference was significant (P <0.01), the difference was not statistically significant (P> 0.05).

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved